Hillhouse, Temasek-backed COVID vaccine developer Clover files for HK IPO

Hillhouse, Temasek-backed COVID vaccine developer Clover files for HK IPO

Photo: National Cancer Institute/Unsplash

Eudora Wang

27 April, 2021

Clover BiopharmaceuticalsCOVID-19GL VenturesHillhouse CapitalTemasek

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.